Welcome to our dedicated page for Vuzix SEC filings (Ticker: VUZI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vuzix's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vuzix's regulatory disclosures and financial reporting.
Vuzix Corporation reported a leadership change in its Enterprise Solutions business unit. On April 22, 2026, the employment of Chris Parkinson, PhD, as president of that unit ended by mutual agreement with the company.
In connection with his departure, 75,000 previously unvested shares of restricted common stock became vested, while 1,000,000 unvested performance stock units were forfeited. The filing does not describe any other changes to compensation or corporate structure related to this event.
Vuzix Corporation reported modest 2025 revenue growth and a sharply reduced loss while advancing its OEM and waveguide strategy. Full-year revenue rose to $6.3 million from $5.8 million, driven by higher M400 smart glasses sales and increased engineering services, especially for defense and security agencies.
The net loss attributable to common shareholders narrowed to $32.3 million, or $0.42 per share, from $73.5 million, or $1.08 per share, as inventory write-downs and operating expenses declined. Operating cash use improved to $18.8 million, and cash and equivalents were $21.2 million with working capital of $22.3 million at year-end.
Management highlighted a strategic shift toward OEM smart glasses, waveguides and defense-related work, and noted that meeting yield and production targets with Quanta Computer secured full funding of Quanta’s contemplated $20 million equity investment, supporting the next phase of smart glasses growth.
Vuzix Corporation reports its 2025 annual results, highlighting ongoing investment in AI-enabled smart glasses and waveguide optics while remaining unprofitable. The company designs and manufactures AR smart glasses, custom waveguides, and display engines for enterprise, medical, defense, security, and select consumer uses, often via ODM/OEM partnerships.
Vuzix recorded a net loss of $32,273,128 for 2025, narrower than prior years, and had an accumulated deficit of $399,858,410 as of December 31, 2025. The aggregate market value of non-affiliate equity was about $189.4 million as of June 30, 2025, and there were 83,158,258 shares outstanding as of March 12, 2026.
The business centers on monocular and binocular smart glasses (including M400/M4000, Blade, Shield, Ultralite, LX1), logistics software, and waveguide components manufactured in New York, with added waveguide R&D capability in California and manufacturing collaboration with Quanta Computer. Vuzix operates in intensely competitive AR and display markets, relies on third‑party component suppliers, and outlines extensive risk factors including continued losses, supply chain dependence, regulatory requirements, and cybersecurity threats. The company had 88 full‑time employees and contractors globally at year-end 2025 and maintains a cybersecurity program aligned with NIST CSF.
Vuzix Corp executive Christopher Iain Parkinson reported an open-market sale of common stock to cover taxes. He sold 11,663 shares at an average price of $2.6895 per share, and held 131,130 shares of Vuzix common stock directly after the transaction.
Quanta Computer Inc. has reported a significant passive stake in Vuzix Corp common stock. Quanta beneficially owns 11,891,897 shares, representing 14.8% of Vuzix’s common stock, based on 80,325,113 shares outstanding as of October 8, 2025, cited from a Vuzix prospectus.
The position consists of 7,692,307 common shares and 4,199,590 common shares issuable upon conversion of 419,959 shares of Series B Preferred Stock, which is convertible into ten common shares per preferred share, subject to customary adjustments. The Series B Preferred Stock generally does not carry voting rights, except for limited matters requiring consent of 66 2/3% of its outstanding shares or as required by law.
Quanta states it holds these securities with sole voting and dispositive power and certifies that they were not acquired, and are not held, for the purpose of changing or influencing control of Vuzix, but instead are reported on a passive Schedule 13G/A basis.
Vuzix Corp reported a significant institutional ownership disclosure. State Street Corporation and its affiliates, including SSGA Funds Management, Inc., beneficially own 7,226,194 shares of Vuzix common stock, representing 9% of the class as of 12/31/2025.
SSGA Funds Management alone reports beneficial ownership of 6,023,602 shares, or 7.5% of the common stock. The shares are held with shared voting and dispositive power and are certified as acquired and held in the ordinary course of business, without any intent to change or influence control of Vuzix.
Vuzix Corporation has filed a prospectus covering the resale by Quanta Computer Inc. of up to 4,199,590 shares of common stock, all issuable upon conversion of an aggregate of 419,959 shares of Series B Preferred Stock issued in prior closings under a securities purchase agreement. These are secondary sales by the selling stockholder, and Vuzix will not receive any proceeds from the resale of these shares.
The Series B Preferred Stock carries a 1.5% annual cumulative dividend on its original issuance price, a liquidation preference ahead of common stock, and is convertible at the holder’s option into ten common shares per preferred share, subject to customary adjustments. Vuzix highlights that large resales of common stock, or expectations of such resales, could put pressure on its share price. Its common stock trades on Nasdaq Capital Market under the symbol VUZI, with a last reported sale price of $3.84 per share on October 7, 2025.
Vuzix Corporation filed an 8-K stating it issued a press release announcing financial results for the period ended September 30, 2025. The press release is furnished as Exhibit 99.1 under Item 2.02.
The company notes this information is furnished pursuant to General Instruction B.2 and is not deemed “filed” under Section 18 of the Exchange Act or incorporated by reference unless specifically referenced.
Vuzix Corporation reported third‑quarter 2025 results with total sales of $1.16 million, down 16% year over year, reflecting lower Smart Glasses unit sales and reduced engineering services. Cost of sales exceeded revenue, producing a gross loss of $411,307.
Operating expenses declined versus last year, narrowing the operating loss to $7.49 million. Net loss was $7.35 million (basic and diluted loss per share $0.09), compared with a $9.22 million loss a year ago. Cash and cash equivalents were $22.61 million at September 30, 2025.
The company raised equity to support liquidity: year‑to‑date ATM sales generated $9.64 million net (including $5.55 million in Q3), and Vuzix issued $10 million of Series B Preferred Stock to Quanta in two 2025 closings tied to milestones. Management disclosed substantial doubt indicators but stated that planned capital raises and operational actions have alleviated doubt about continuing as a going concern.
Vuzix Corporation filed an S-3 shelf registration allowing a selling stockholder to offer registered shares for resale. The prospectus references incorporated SEC reports including the Form 10-K for fiscal 2024 and multiple 10-Qs and 8-Ks through September 23, 2025. The document states there were 80,325,113 shares of common stock outstanding as of October 8, 2025 and discloses that certain shares represent conversion shares from Series B preferred stock. The prospectus lists permitted sale methods (brokered ordinary transactions, block trades, principal purchases and resales, exchange distributions, privately negotiated transactions, short sales after effectiveness, options and hedging), and explains the selling stockholder may sell all, some or none of the registered shares. The filing is signed by the CEO and CFO and several directors on October 8, 2025.